Kenneth C Carter insider trades: Avalon Pharmaceuticals (AVRX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Kenneth reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 23, 2008 | AVRX | ↑ Buy | 4,832 | $2.58 | $12K | Direct | Jan 23, 2008 (0d) |
| Jan 17, 2008 | AVRX | ↓ Sell | 2,032 | $2.53 | $5K | Direct | Jan 23, 2008 (6d) |
| Aug 30, 2006 | AVRX | ↑ Buy | 3,000 | $2.99 | $9K | Direct | Aug 31, 2006 (1d) |
| Aug 22, 2006 | AVRX | ↑ Buy | 2,000 | $3.27 | $7K | Direct | Aug 24, 2006 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Kenneth C Carter's insider trades
Kenneth C Carter is President and CEO at Avalon Pharmaceuticals (AVRX). Since Aug 22, 2006, Kenneth has reported 3 open-market purchases worth $28K and 1 sale worth $5K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (4 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AVRX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.